TENMAK

Name

TENMAK

Legal name

Türkiye Enerji, Nükleer ve Maden Araştırma Kurumu

Website

https://tenmak.gov.tr

Company type

Private

Founded year

2020

Operating status

Operating

Headcount range

501–1,000 employees

Ownership category

akta.pro rank

Product category

Nuclear and Energy Research Services

NAICS

Analytical Laboratory Instrument Manufacturing (334516), Testing Laboratories and Services (541380), Research and Development in the Physical, Engineering, and Life Sciences (54171)

SIC

Industrial Instruments For Measurement, Display, And Control (3823), X-Ray Apparatus & Tubes & Related Irradiation Apparatus (3844), Services-Testing Laboratories (8734)

akta.pro primary industry

Radiation Detection Instruments & Systems (Portal monitors, spectrometers, contamination monitors) (EUAKAIAK)

akta.pro secondary industries

Industrial Radiography & NDT Services (Gamma radiography, source handling, field inspection) (EUAKAIAF), Nuclear Materials Testing, Assay & Characterization Services (NDA/NDE, radiochemistry, materials analysis) (EUAKAIAL)

Keywords

• Nuclear research services
• Radiation monitoring devices
• Radiopharmaceuticals production
• Dosimetry calibration
• Energy research programs

Headquarters

HQ city

Ankara

HQ country

Türkiye

HQ region

Europe

Offices6 records

Markets served

GTM type

B2B

Offering type

Services

Revenue model

1. Government Budget Allocation: Primary funding through Turkish government annual budget allocations for research and development activities
2. Industrial and Laboratory Services: Fee-based services including calibration, analysis services, radioactive waste management, radiation monitoring equipment sales, and training programs

Pricing tiers

Go-to-market motion1 record

Distribution channels2 records

Marketing channels4 records

Core offering

TENMAK is a Turkish state-affiliated research institution conducting applied research across energy, nuclear, and mining domains through five specialized institutes. It manufactures and supplies radiation detection and dosimetry products, provides calibration and radiation measurement services, and operates advanced research infrastructure including the 30 MeV Proton Accelerator and TR-2 Research Reactor. The agency also develops radiopharmaceuticals and supports industrial applications such as non-destructive testing and X-ray spectroscopy.

Product overview

TENMAK (Türkiye Enerji, Nükleer ve Maden Araştırma Kurumu) is Turkey's national research institution for energy, nuclear, and mining technologies. The organization offers a diverse portfolio spanning both physical products and service offerings. Physical products include portable radiation dose measurement devices, radiation monitors, radiopharmaceuticals, radioactive standard reference materials, personal electronic dosimeters, and the domestically developed İ-RİS Radiation Monitoring System. Key facilities include the 30 MeV Proton Accelerator Facility producing critical medical radioisotopes. Services encompass radioactivity measurement and analysis, radioactive waste management, personal dosimetry, calibration, quality control, project engineering, nuclear electronic device production, and training programs. Additionally, TENMAK operates AKIM (Akselerasyon, Kuluçka ve İnovasyon Merkezi), an innovation center supporting entrepreneurs through multiple programs including the Girişimci Destek Programı, Çekirdek Destek Programı, and Kadın Girişimci Destek Programı, alongside scholarship programs and various technology support initiatives (TAGEP, TUGEP, TUDEP, TİGEP, TARGEP).

Differentiator

Problem solved

Functional benefit

Brands

• AKIM (Akselerasyon, Kuluçka ve İnovasyon Merkezi): Acceleration, Incubation and Innovation Center - a platform under TENMAK that brings together public institutions, private sector, academia and entrepreneurs in energy, nuclear and mining sectors.

Products and services

• I-RIS (Industrial Radiation Imaging System)

Quantifiable outcome

• 150 million TL EU funding secured for solar panel end-of-life management project
• +2 more outcomes

Named customers5 records

Segments4 records

Technology focussed Yes

API detail

Has API

No

API docs

API detail

Core technology

AI maturity

App detail

Feature4 records

Partnerships

Seven partnerships are on record, tiered core and minor.

• NÜTED Nükleer Teknik Destek A.Ş.coreStrategic or Co-development Partner · 27 July 2026Capacity building cooperation agreement. Joint training program on 'Occupational Radiation Safety Training for Workers of Accelerator Facility for Radioisotope/Radiopharmaceutical Production' conducted in Ashgabat, Turkmenistan.
• Eti Maden İşletmeleri Genel MüdürlüğücoreStrategic or Co-development Partner · 3 December 2025Co-organization of BORON2025 International Boron Symposium (December 3-5, 2025) on boron's strategic role in energy transformation, hydrogen storage, nuclear energy, and advanced materials.
• Gazi ÜniversitesiminorStrategic or Co-development Partner · 1 January 2025Joint project 'R260 Rail Steel Wear Resistance Enhancement with Boron-Based Surface Modifications' under UDHAM-RS-2025-01 Railway System Technologies Support Call Program.
• SESAME (Ortadoğu Sinkrotron Işığı Deneysel Bilim ve Uygulamaları Uluslararası Merkezi)coreStrategic or Co-development PartnerTENMAK represents Turkey as a founding member of SESAME. Turkey has built the TXPES (Turkish Soft X-ray Photoelectron Spectroscopy) beamline - the first synchrotron beamline built by a SESAME member state.
• ODTÜ-GÜNAM (Orta Doğu Teknik Üniversitesi - Güneş Enerjisi Uygulama ve Araştırma Merkezi)coreStrategic or Co-development PartnerCollaboration on agrivoltaic systems research project 'Mutant Genotypes' Microclimatic Adaptation and Yield-Quality Performance Analysis in Agrivoltaic Systems' led by TENMAK with NÜKEN and TEMEN institutes.
• ODTÜ İVMER (İyonize Radyasyon Merkezi)coreStrategic or Co-development PartnerCollaboration through RADNEXT 2030 EU Horizon Europe project. ODTÜ-SDH (Scattering Beamline) at TENMAK's Proton Accelerator Facility was officially included as a proton test facility in the RADNEXT 2030 system.
• T.C. Tarım ve Orman Bakanlığı, Gıda ve Kontrol Genel MüdürlüğüminorImplementation/ SI/ Consulting PartnerTraining provided to Ministry staff on food irradiation facilities and inspection, Turkish and international regulations, applications, and detection methods.

Scale indicators5 records

Recent moves7 records

Expansion highlights6 records

Direct peers

• Japan Atomic Energy Agency (JAEA): Japan's comprehensive nuclear R&D organization operating multiple research facilities including reactors, accelerators, and fuel cycle research. Closest peer in terms of integrated nuclear research scope and government affiliation.
• Australian Nuclear Science and Technology Organisation (ANSTO): Australia's national nuclear science and technology organization, operating the OPAL research reactor and producing medical radioisotopes (Mo-99). Most direct functional peer to TENMAK as a government nuclear research institution with commercial isotope production and broad scientific mandate.
• Korea Atomic Energy Research Institute (KAERI): South Korea's primary government nuclear research institute operating research reactors, conducting fuel cycle R&D, and producing radioisotopes. Comparable scale, mandate, and structure to TENMAK with similar focus on energy independence and isotope supply.
• Bhabha Atomic Research Centre (BARC): India's premier nuclear research facility under the Department of Atomic Energy, operating research reactors and producing medical radioisotopes. Highly comparable multi-institute government nuclear research model with similar national strategic mandate.
• Canadian Nuclear Laboratories (CNL): Canada's nuclear science and technology laboratory operated as a government-owned, contractor-operated entity. Comparable mandate covering nuclear research, radioisotope production, and waste management under government oversight.

Broad incumbents

• IBA (Ion Beam Applications): Belgian commercial leader in proton therapy and radiopharma production solutions, including PET isotope production technology. Direct commercial competitor in the radioisotope production segment where TENMAK's proton accelerator competes.
• Mirion Technologies: Global leader in radiation detection, measurement, and monitoring solutions serving nuclear, medical, defense, and industrial markets. Comparable product portfolio to TENMAK's radiation monitors and dosimeters, but at commercial global scale.
• Curium Pharma: Global nuclear medicine company producing PET and SPECT radiopharmaceuticals. Commercial competitor in the medical radioisotope supply market that TENMAK serves for Turkish hospitals.

Others

• SESAME (Synchrotron-light for Experimental Science and Applications in the Middle East): International synchrotron facility where TENMAK built and operates the TXPES beamline. Strategic partner and ecosystem player rather than a competitor, but comparable as a multinational scientific facility in the same research category.

Regional players

• Institute of Nuclear Chemistry and Technology (INCT): Poland's nuclear chemistry research institute producing radiopharmaceuticals and conducting radiation chemistry research. Comparable at smaller scale; serves as a useful regional European peer outside the Western European mainstream.

Market position

Strengths5 records

Weaknesses5 records

Competitive moat4 records

Key risks5 records

Key highlights7 records

Customer concentration

• LinkedInlinkedin.com/company/tenmakbaskanlik

Revenue estimate

Valuation estimate

Number of profiles

Funding overview

Funding rounds

Investors

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

M&A

Investments

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Frequently asked questions about TENMAK